Citius Oncology Inc (CTOR)

1.069 -0.15 (-12.38%) USD  |  NASDAQ  |  Nov 14, 16:00
1.10 +0.03 (+2.90%) After-Hours: 20:00
More

Citius Oncology Income from Continuing Operations (Quarterly)

Income from Continuing Operations (Quarterly) Chart

View Income from Continuing Operations (Quarterly) for CTOR.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00

Historical Income from Continuing Operations (Quarterly) Data

View and export this data back to . Upgrade now.
Date Value

Income from Continuing Operations Definition

Income Statement line item that does not account extraordinary items and discontinued operations. This metric is frequently used because it excludes items that are unlikely to happen the next reporting period.

Read full definition.

Income from Continuing Operations (Quarterly) Range, Past 5 Years

--
Minimum
--
Maximum
--
Average
--
Median

Income from Continuing Operations (Quarterly) Benchmarks

Citius Pharmaceuticals Inc Upgrade
NovaBay Pharmaceuticals Inc Upgrade
Palatin Technologies Inc Upgrade
iBio Inc Upgrade
Theriva Biologics Inc Upgrade